Clinical Trials Logo

Severe Adverse Reactions clinical trials

View clinical trials related to Severe Adverse Reactions.

Filter by:
  • None
  • Page 1

NCT ID: NCT04479553 Recruiting - Adverse Drug Events Clinical Trials

Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.

Start date: August 17, 2020
Phase:
Study type: Observational [Patient Registry]

This registry aims to monitor the safety of Qizhi Tongluo Capsules and to identify the potential risk factors for its adverse drug reactions.

NCT ID: NCT03640884 Recruiting - Adverse Drug Event Clinical Trials

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

Start date: February 18, 2019
Phase:
Study type: Observational [Patient Registry]

This registry aims to monitor the safety of Xueshuantong Injection and to identify the potential risk factors for the adverse drug reactions.

NCT ID: NCT02239237 Completed - Adverse Drug Events Clinical Trials

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

Start date: September 2014
Phase:
Study type: Observational

This registry aims to monitor the safety of Compound Kuh-seng Injection and to identify the potential risk factors for the adverse drug reactions. Compound Kuh-seng Injection is a kind of natural compound injection extracted from herbs Kuh-seng (Radix Sophorae Flavescentis) and Rhizoma Heterosmilacis Japonicae.